Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NexPoint Credit Strategies Fund, now operating as NexPoint Diversified Real Estate Trust (NYSE: NXDT), is a publicly traded investment vehicle that transitioned from a closed-end fund to a diversified real estate investment trust (REIT) in July 2022. Managed by NexPoint Advisors, L.P., the entity historically focused on opportunistic credit investments across various sectors, including healthcare and life sciences. Following its conversion, the trust primarily invests in a diverse portfolio of real estate assets, including life science facilities, healthcare-related properties, and multifamily residential units. The company functions as a financial and real estate entity providing capital and infrastructure rather than a biotechnology or pharmaceutical developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NexPoint Credit Strategies Fund.